MBX
MBX Biosciences
157 hedge funds and large institutions have $1.57B invested in MBX Biosciences in 2026 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 43 increasing their positions, 47 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more capital invested
Capital invested by funds: $1.53B → $1.57B (+$40.7M)
9% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 47
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
157
Holding in Top 10
6
Calls
$3.68M
Puts
$1.46M
Top Buyers
| 1 | +$99.3M | |
| 2 | +$55.2M | |
| 3 | +$37.3M | |
| 4 |
CP
Caligan Partners
New York
|
+$28.9M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$16.1M |
Top Sellers
| 1 | -$45.8M | |
| 2 | -$21.5M | |
| 3 | -$16.7M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$13.3M |
| 5 |
D.E. Shaw & Co
New York
|
-$13M |
